Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice

A S Apt1, I B Kramnik, A M Moroz

  • 1Experimental Immunogenetics Laboratory, Central Institute for Tuberculosis, Moscow, USSR.

Immunology
|June 1, 1991
PubMed

Insights

Lung macrophages in mice infected with Mycobacterium tuberculosis inhibit T-cell proliferation. This suppression involves both infection-specific and non-specific mechanisms, with prostaglandin E (PGE) playing a key role in non-specific inhibition.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Chronic Mycobacterium tuberculosis infection leads to complex immune responses within the lung.
  • Understanding cellular interactions in the lung is crucial for developing effective tuberculosis treatments.

Purpose of the Study:

  • To investigate the proliferative responses of lung interstitial cells to mycobacterial antigens and non-specific stimuli in infected mice.
  • To elucidate the mechanisms by which lung macrophages suppress T-cell proliferation during chronic tuberculosis infection.

Main Methods:

  • Studied proliferative responses of lung interstitial cells from Mycobacterium tuberculosis-infected CBA mice.
  • Assessed responses to purified protein derivative (PPD) and non-specific stimuli.
  • Investigated the role of macrophages and specific cell populations in T-cell suppression.

Main Results:

  • Purified protein derivative (PPD)-reactive lymphocytes were found in the lung wall tissue.
  • Lung macrophages completely inhibited the proliferative capacity of these PPD-reactive lymphocytes.
  • Macrophages also suppressed the proliferation of immune lymph node T cells via infection-specific and non-specific mechanisms.
  • Non-specific suppression was mediated primarily by prostaglandin E (PGE).
  • Specific suppression involved I-J+ Lyt-2- nylon-wool-adherent cells and was weakly influenced by PGE.

Conclusions:

  • Lung macrophages play a critical role in suppressing T-cell responses during chronic Mycobacterium tuberculosis infection.
  • Both prostaglandin E (PGE)-dependent and independent mechanisms contribute to macrophage-mediated suppression.
  • Specific suppression involves distinct cell populations within the responder T cells.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...